InvestorsHub Logo
Followers 5
Posts 61
Boards Moderated 0
Alias Born 12/01/2014

Re: drcs post# 473397

Sunday, 05/15/2022 3:56:46 PM

Sunday, May 15, 2022 3:56:46 PM

Post# of 715423
I know we all have read of the competition for cancer cures among the various schools and labs and how keen that competition can be. Looking up Lewis C. Cantley, the Editor-in-Chief for AACR on Google one finds that Cantley is also involved in cancer cure in a big way.

Agios Pharmaceuticals
Dr. Cantley is a founder of Agios, a biopharmaceutical company dedicated to the discovery and development of novel medicines in the emerging field of cancer metabolism and rare genetic disorders of metabolism.

Would he be biased against a cure from a small bio company?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News